Search by Drug Name or NDC
NDC 68071-1395-03 Benzonatate 200 mg/1 Details
Benzonatate 200 mg/1
Benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NuCare Pharmaceuticals,Inc.. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 68071-1395-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 68071-1395 |
|---|---|
| Product ID | 68071-1395_0bdef49b-25e4-8335-e063-6394a90abed0 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Benzonatate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benzonatate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | NuCare Pharmaceuticals,Inc. |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206948 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68071-1395-03 (68071139503)
| NDC Package Code | 68071-1395-3 |
|---|---|
| Billing NDC | 68071139503 |
| Package | 30 CAPSULE in 1 BOTTLE (68071-1395-3) |
| Marketing Start Date | 2019-10-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |